Evotec partner Haplogen enters into collaboration with Bayer
15-Aug-2018 -
Evotec AG announced that Haplogen GmbH, a Vienna-based biotechnology company and collaboration partner of Evotec, has entered into a multi-year drug discovery and development collaboration with Bayer AG to identify new therapeutics with applications in pulmonary diseases such as chronic ...
Bayer
chronic obstructive pulmonary disease
drug development
+4